PT视讯(中国)

关于PT视讯(中国)

致力于纳米抗体创新药物研发

关于PT视讯(中国)

科研论文

截止现在，PT视讯(中国)生物研发团队在具有重要影响力的期刊上发表研究论文多篇。

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

发表于:J Nanobiotechnology. 2023 Nov 6;21(1):410

查看更多内容

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis

发表于:Int J Nanomedicine. 2023 Sep 21;18:5407-5422

查看更多内容

Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma

发表于:Respiratory Research. 2022 Nov 19;23(1):316

查看更多内容

Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein

发表于:Cells. 2022 Oct 24;11(21):3355

查看更多内容

Atomically dispersed Mn boosting photoelectrochemical SARS-CoV-2 spike protein immunosensing on carbon nitride

发表于:Journal of Environmental Chemical Engineering. 2022 Dec;10(6):108697

查看更多内容

Evaluation of SARS-CoV-2-neutralizing Nanobody Using Virus Receptor Binding Domain Administered Model Mice-Research-2022

发表于:Research (Wash D C). 2022 Jul 22;2022:9864089

查看更多内容

总计 24 123 4